- Home
- PCOR vs BBIO Comparison
PCOR vs BBIO Comparison
Compare PCOR & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCOR
- BBIO
- Stock Information
- Founded
- PCOR 2003
- BBIO 2015
- Country
- PCOR United States
- BBIO United States
- Employees
- PCOR N/A
- BBIO N/A
- Industry
- PCOR Computer Software: Prepackaged Software
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- PCOR Technology
- BBIO Health Care
- Exchange
- PCOR Nasdaq
- BBIO Nasdaq
- Market Cap
- PCOR 10.5B
- BBIO 9.4B
- IPO Year
- PCOR 2021
- BBIO 2019
- Fundamental
- Price
- PCOR $75.07
- BBIO $54.36
- Analyst Decision
- PCOR Buy
- BBIO Strong Buy
- Analyst Count
- PCOR 21
- BBIO 16
- Target Price
- PCOR $81.95
- BBIO $65.25
- AVG Volume (30 Days)
- PCOR 1.0M
- BBIO 1.8M
- Earning Date
- PCOR 11-05-2025
- BBIO 11-11-2025
- Dividend Yield
- PCOR N/A
- BBIO N/A
- EPS Growth
- PCOR N/A
- BBIO N/A
- EPS
- PCOR N/A
- BBIO N/A
- Revenue
- PCOR $1,232,484,000.00
- BBIO $235,812,000.00
- Revenue This Year
- PCOR $15.31
- BBIO $115.12
- Revenue Next Year
- PCOR $12.88
- BBIO $65.29
- P/E Ratio
- PCOR N/A
- BBIO N/A
- Revenue Growth
- PCOR 16.08
- BBIO 7.62
- 52 Week Low
- PCOR $53.71
- BBIO $21.72
- 52 Week High
- PCOR $88.92
- BBIO $57.49
- Technical
- Relative Strength Index (RSI)
- PCOR 57.15
- BBIO 53.18
- Support Level
- PCOR $69.53
- BBIO $52.75
- Resistance Level
- PCOR $75.13
- BBIO $56.33
- Average True Range (ATR)
- PCOR 2.90
- BBIO 1.64
- MACD
- PCOR 0.10
- BBIO -0.32
- Stochastic Oscillator
- PCOR 91.33
- BBIO 34.04
About PCOR Procore Technologies Inc.
Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.